720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers
oleh: Edith A Perez, Lu Xu, Antonio Giordano, Justin Kenkel, Shelley E Ackerman, Michael N Alonso, Sharon Wilks, Aparna R Parikh, Danlin Cai, Damon Demady
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.